Annual Drug Patent Expirations for EMERPHED
Emerphed is a drug marketed by Nexus Pharms and is included in a single NDA. It’s obtainable from one provider. There are 4 patents defending this drug.
This drug has eight patent relations in eight nations.
The generic ingredient in EMERPHED is ephedrine sulfate. One provider is listed for this compound. Extra particulars can be found on the ephedrine sulfate profile web page.
For extra info on how DrugPatentWatch may help along with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Initially revealed at New patent for Nexus Pharms drug EMERPHED